{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:36:44Z","timestamp":1790980604648,"version":"4.1.0"},"reference-count":245,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Toxicology"],"published-print":{"date-parts":[[1995,1]]},"DOI":"10.3109\/10408449509089888","type":"journal-article","created":{"date-parts":[[2007,11,27]],"date-time":"2007-11-27T23:31:05Z","timestamp":1196206265000},"page":"207-235","source":"Crossref","is-referenced-by-count":152,"title":["Idiosyncratic Liver Toxicity of Nonsteroidal Antiinflammatory Drugs: Molecular Mechanisms and Pathology"],"prefix":"10.1080","volume":"25","author":[{"given":"Urs A.","family":"Boelsterli","sequence":"first","affiliation":[{"name":"Institute of Toxicology, Swiss Federal Institute of Technology and University of Zurich, CH-8603, Schwerzenbach, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyman J.","family":"Zimmerman","sequence":"additional","affiliation":[{"name":"George Washington University and Armed Forces Institute of Pathology, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Kretz-Rommel","sequence":"additional","affiliation":[{"name":"Institute of Toxicology, Swiss Federal Institute of Technology and University of Zurich, CH-8603, Schwerzenbach, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2008,9,25]]},"reference":[{"key":"e_1_2_1_2_1","volume-title":"Hepatotoxicity. The Adverse Effects of Drugs and Other Chemicals on the Liver","author":"Zimmerman H. J","year":"1978","unstructured":"Zimmerman H. J. Hepatotoxicity. The Adverse Effects of Drugs and Other Chemicals on the Liver. Appleton-Century-Crofts, New York 1978"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb05647.x"},{"key":"e_1_2_1_4_1","volume-title":"Nonsteroidal Antiinflammatory Drugs","author":"Lombardino J. G.","year":"1985","unstructured":"Nonsteroidal Antiinflammatory Drugs, J. G. Lombardino. John Wiley & Sons, New York 1985"},{"key":"e_1_2_1_5_1","volume-title":"Anti-Inflammatory and Anti-Rheumatic Drugs","author":"Rainsford K. D.","year":"1985","unstructured":"Anti-Inflammatory and Anti-Rheumatic Drugs, K. D. Rainsford. CRC Press, Boca Raton, FL 1985"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-8422(23)00521-9"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90396-7"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/367215a0"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198409040-00007"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1983.tb02874.x"},{"key":"e_1_2_1_11_1","first-page":"197","article-title":"Stereoselective metabolism of antiinflammatory 2-arylpropionates","volume":"2","author":"Mayer J. M","year":"1990","unstructured":"Mayer J. M. Stereoselective metabolism of antiinflammatory 2-arylpropionates. Acta Pharm. Nord. 1990; 2: 197","journal-title":"Acta Pharm. Nord."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.39.1075"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00290247"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199106000-00003"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.33.040193.002251"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1991.tb03743.x"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/chir.530050703"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03450200085037"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.49.7.489"},{"key":"e_1_2_1_20_1","first-page":"562","article-title":"Rare adverse reactions to nonsteroidal antiinflammatory drugs","volume":"12","author":"O'Brien W. M.","year":"1985","unstructured":"O'Brien W. M., Bagby G. F. Rare adverse reactions to nonsteroidal antiinflammatory drugs. J. Rheumatol. 1985; 12: 562","journal-title":"J. Rheumatol."},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040488"},{"key":"e_1_2_1_22_1","first-page":"1696","article-title":"Hepatotoxicity of nonsteroidal antiinflammatory drugs","volume":"87","author":"Rabinovitz M.","year":"1992","unstructured":"Rabinovitz M., VanThiel D. H. Hepatotoxicity of nonsteroidal antiinflammatory drugs. Am. J. Gastroenterol. 1992; 87: 1696","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_23_1","first-page":"128","article-title":"Hepatic toxicity of nonsteroidal antiinflammatory drugs","volume":"3","author":"Lewis J. H","year":"1984","unstructured":"Lewis J. H. Hepatic toxicity of nonsteroidal antiinflammatory drugs. Clin. Pharm. 1984; 3: 128","journal-title":"Clin. Pharm."},{"key":"e_1_2_1_24_1","first-page":"6","article-title":"Hepatotoxicity of antirheumatic drugs","volume":"17","author":"Tolman K. G","year":"1990","unstructured":"Tolman K. G. Hepatotoxicity of antirheumatic drugs. J. Rheumatol. 1990; 17: 6, Suppl. 22","journal-title":"J. Rheumatol."},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199311000-00004"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1992.tb04511.x"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6858.865"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410110039007"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-194802000-00002"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1936.02770360006003"},{"key":"e_1_2_1_31_1","first-page":"591","volume-title":"Diseases of the Liver, 6th ed","author":"Zimmerman H. J.","year":"1987","unstructured":"Zimmerman H. J., Maddrey W. C. Toxic and drug-induced hepatitis. Diseases of the Liver, 6th ed, L. Schiff, E. R. Schiff. Lippincott, Philadelphia 1987; 591"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780250914"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1953.00240230046005"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.23.5.397"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.24.1.61"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198600324-00010"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840010311"},{"key":"e_1_2_1_38_1","first-page":"556","article-title":"H\u00e9patite chronique active \u00e0 la clom\u00e9tacine et antig\u00e8ne HLA B8","volume":"7","author":"Chagnon J. P.","year":"1983","unstructured":"Chagnon J. P., Barge J. H\u00e9patite chronique active \u00e0 la clom\u00e9tacine et antig\u00e8ne HLA B8. Gastroent\u00e9rol Clin. Biol. 1983; 7: 556","journal-title":"Gastroent\u00e9rol Clin. Biol."},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1986.tb00270.x"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(90)90077-5"},{"key":"e_1_2_1_41_1","first-page":"171","volume-title":"Nonsteroidal Anti-inflammatory Drugs","author":"Zimmerman H. J","year":"1994","unstructured":"Zimmerman H. J. Hepatic injury associated with nonsteroidal anti-inflammatory drugs. Nonsteroidal Anti-inflammatory Drugs, A. J. Lewis, D. E. Furst. Marcel Dekker, New York 1994; 171"},{"key":"e_1_2_1_42_1","article-title":"Diclofenac-associated hepatic injury analysis of 181 cases","author":"Banks T.","unstructured":"Banks T., Zimmerman H. J., Harter J., Ishak K. G. Diclofenac-associated hepatic injury analysis of 181 cases. Hepatology, in press","journal-title":"Hepatology"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6329.1605"},{"key":"e_1_2_1_44_1","first-page":"316","article-title":"H\u00e9patite au diclofenac","volume":"7","author":"Babany G.","year":"1983","unstructured":"Babany G., Pessayre D., Benhamou J. P. H\u00e9patite au diclofenac. Gastroent\u00e9rol. Clin. Biol. 1983; 7: 316","journal-title":"Gastroent\u00e9rol. Clin. Biol."},{"key":"e_1_2_1_45_1","first-page":"1847","article-title":"Diclofenac hepatitis","volume":"13","author":"Deshayes P.","year":"1984","unstructured":"Deshayes P., Leloet X., Bercoff E., Fouin-Fortunet H. Diclofenac hepatitis. Nouv. Presse M\u00e9d. 1984; 13: 1847","journal-title":"Nouv. Presse M\u00e9d."},{"key":"e_1_2_1_46_1","first-page":"881","article-title":"H\u00e9patite aigue mortelle au cours d'un traitement par le diclofenac (Voltarene)","volume":"8","author":"Lascar G.","year":"1984","unstructured":"Lascar G., Grippon P., Levy V. G. H\u00e9patite aigue mortelle au cours d'un traitement par le diclofenac (Voltarene). Gastroent\u00e9rol Clin. Biol. 1984; 8: 881","journal-title":"Gastroent\u00e9rol Clin. Biol."},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.27.11.1390"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.62.723.63"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03450200068033"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.11.1381"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199104000-00018"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01316809"},{"key":"e_1_2_1_53_1","first-page":"985","article-title":"H\u00e9patite subfulminante mortelle au diclof\u00e9nac","volume":"113","author":"Selz F.","year":"1993","unstructured":"Selz F., Cereda J. M. H\u00e9patite subfulminante mortelle au diclof\u00e9nac. Rev. M\u00e9d. Suisse Romande 1993; 113: 985","journal-title":"Rev. M\u00e9d. Suisse Romande"},{"key":"e_1_2_1_54_1","volume-title":"Drug-induced Liver Injury","author":"Stricker B. H. C.","year":"1985","unstructured":"Stricker B. H. C., Spoelstra P. Drug-induced Liver Injury. Elsevier, Amsterdam 1985"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007997409115265"},{"key":"e_1_2_1_56_1","first-page":"3035","article-title":"H\u00e9patite au clom\u00e9tacine","volume":"7","author":"Lenoir C.","year":"1978","unstructured":"Lenoir C., Labayle D., Buffet C. H\u00e9patite au clom\u00e9tacine. Now. Presse M\u00e9d. 1978; 7: 3035","journal-title":"Now. Presse M\u00e9d."},{"key":"e_1_2_1_57_1","first-page":"213","article-title":"H\u00e9patite \u00e0 la clom\u00e9tacine","volume":"8","author":"Manigand G.","year":"1979","unstructured":"Manigand G., Pointud P., Taillandier J., Martin E., Bard N., Benoist J. H\u00e9patite \u00e0 la clom\u00e9tacine. Nouv. Presse M\u00e9d. 1979; 8: 213","journal-title":"Nouv. Presse M\u00e9d."},{"key":"e_1_2_1_58_1","first-page":"2719","article-title":"Atteintes h\u00e9patiques apr\u00e8s clom\u00e9tacine 6 cas dont 2 mortels","volume":"10","author":"Mamou P.","year":"1981","unstructured":"Mamou P., Levy V. G. Atteintes h\u00e9patiques apr\u00e8s clom\u00e9tacine 6 cas dont 2 mortels. Nouv. Presse M\u00e9d. 1981; 10: 2719","journal-title":"Nouv. Presse M\u00e9d."},{"key":"e_1_2_1_59_1","first-page":"1038","article-title":"Pericholiangitie chez un adulte trait\u00e9 par clom\u00e9tacine","volume":"7","author":"Hillion D.","year":"1983","unstructured":"Hillion D., Filsenheld C., Oberlin P. Pericholiangitie chez un adulte trait\u00e9 par clom\u00e9tacine. Gastroent\u00e9rol. Clin. Biol. 1983; 7: 1038","journal-title":"Gastroent\u00e9rol. Clin. Biol."},{"key":"e_1_2_1_60_1","first-page":"679","article-title":"H\u00e9patite \u00e0 la clom\u00e9tacine","volume":"103","author":"Tassou J. J.","year":"1981","unstructured":"Tassou J. J., Bretagne J. F., Marion J. H\u00e9patite \u00e0 la clom\u00e9tacine. Concours M\u00e9d. 1981; 103: 679","journal-title":"Concours M\u00e9d."},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1159\/000198597"},{"key":"e_1_2_1_62_1","first-page":"2641","article-title":"Insuffisance r\u00e9nale aigue et H\u00e9patite lors d'un traitement par clom\u00e9tacine","volume":"11","author":"Parini M.","year":"1982","unstructured":"Parini M., Benevent D., Leroux-Robert C. Insuffisance r\u00e9nale aigue et H\u00e9patite lors d'un traitement par clom\u00e9tacine. Nouv. Presse M\u00e9d. 1982; 11: 2641","journal-title":"Nouv. Presse M\u00e9d."},{"key":"e_1_2_1_63_1","first-page":"99","article-title":"Clometacineinduced hepatitis: a fatal crisis","volume":"7","author":"Poitrine A.","year":"1983","unstructured":"Poitrine A., Poynard T., Naveu S. Clometacineinduced hepatitis: a fatal crisis. Gastroent\u00e9rol. Clin. Biol. 1983; 7: 99","journal-title":"Gastroent\u00e9rol. Clin. Biol."},{"key":"e_1_2_1_64_1","first-page":"318","article-title":"H\u00e9patite aigue \u00e0 la clom\u00e9tacine. Inter\u011bt du dosage des anticorps anti-noyaux et anti-muscle lisse","volume":"7","author":"Braillon A.","year":"1983","unstructured":"Braillon A., Capron J. P., Quichaud J. H\u00e9patite aigue \u00e0 la clom\u00e9tacine. Inter\u011bt du dosage des anticorps anti-noyaux et anti-muscle lisse. Gastroent\u00e9rol. Clin. Biol. 1983; 7: 318","journal-title":"Gastroent\u00e9rol. Clin. Biol."},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92073-1"},{"key":"e_1_2_1_66_1","first-page":"139","article-title":"Un nouveau cas mortel de cirrhose d \u00e0 la clom\u00e9tacine","volume":"65","author":"Meyer C.","year":"1984","unstructured":"Meyer C., Chassagnon C. Un nouveau cas mortel de cirrhose d \u00e0 la clom\u00e9tacine. J. M\u00e9d. Lyon 1984; 65: 139","journal-title":"J. M\u00e9d. Lyon"},{"key":"e_1_2_1_67_1","first-page":"833","article-title":"H\u00e9patites chroniques actives associ\u00e9es \u00e0 des anticorps anti-DNA natif: fr\u00e9quence de l'\u00e9tiologie m\u00e9dicamenteuse","volume":"8","author":"Metreau J. M.","year":"1984","unstructured":"Metreau J. M., Andre C., Zafrani E. S., Girdin S. M., Carvana A., Dhumeaux D. H\u00e9patites chroniques actives associ\u00e9es \u00e0 des anticorps anti-DNA natif: fr\u00e9quence de l'\u00e9tiologie m\u00e9dicamenteuse. Gastroent\u00e9rol. Clin. Biol. 1984; 8: 833","journal-title":"Gastroent\u00e9rol. Clin. Biol."},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197901183000330"},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-91-4-656_1"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1980.03310030045026"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80283-1"},{"key":"e_1_2_1_72_1","first-page":"430","article-title":"Sulindac (Clinoril) and cholestatic jaundice","volume":"94","author":"McIndoe G. A. J.","year":"1981","unstructured":"McIndoe G. A. J., Menzies K. W., Reddy J. Sulindac (Clinoril) and cholestatic jaundice. N. Z. Med. J. 1981; 94: 430","journal-title":"N. Z. Med. J."},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(81)90023-8"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.23.10.875"},{"key":"e_1_2_1_75_1","first-page":"334","article-title":"Cholestatic jaundice caused by sulindac","volume":"25","author":"Giroux Y.","year":"1982","unstructured":"Giroux Y., Moreau M., Kass T. G. Cholestatic jaundice caused by sulindac. Can. J. Surg. 1982; 25: 334","journal-title":"Can. J. Surg."},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1982.00340200050013"},{"key":"e_1_2_1_77_1","first-page":"712","article-title":"H\u00e9patite au sulindac: une observation avec revue des trois pr\u00e9c\u00e9dents","volume":"6","author":"Kammerer J.","year":"1982","unstructured":"Kammerer J., Sabaardeil S., Rumeau J. L., Salson A., El-Hage A. H\u00e9patite au sulindac: une observation avec revue des trois pr\u00e9c\u00e9dents. Gastroenterol. Clin. Biol. 1982; 6: 712","journal-title":"Gastroenterol. Clin. Biol."},{"key":"e_1_2_1_78_1","first-page":"512","article-title":"Hepatitis, toxic epidermal neurolysis and pancreatitis in association with sulindac therapy","volume":"10","author":"Klein S. M.","year":"1983","unstructured":"Klein S. M., Muhammad A. K. Hepatitis, toxic epidermal neurolysis and pancreatitis in association with sulindac therapy. J. Rheumatol. 1983; 10: 512","journal-title":"J. Rheumatol."},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.24.12.1199"},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1985.tb02758.x"},{"key":"e_1_2_1_81_1","first-page":"205","article-title":"Sulindac hepatotoxicity: a case report and review","volume":"23","author":"Gallanosa A. G","year":"1985","unstructured":"Gallanosa A. G. Sulindac hepatotoxicity: a case report and review. Clin. Toxicol. 1985; 23: 205","journal-title":"Clin. Toxicol."},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1177\/096032718600500112"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1980.03300380042021"},{"key":"e_1_2_1_84_1","first-page":"546","article-title":"L'h\u00e9patotoxicit\u00e9 du sulindac: une nouvelle observation","volume":"9","author":"Bodin F.","year":"1985","unstructured":"Bodin F., Habibi B., Legendre C., Schaeffer-Plumet J., Riallin P., Daris F. L'h\u00e9patotoxicit\u00e9 du sulindac: une nouvelle observation. Gastroent\u00e9rol. Clin. Biol. 1985; 9: 546","journal-title":"Gastroent\u00e9rol. Clin. Biol."},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90428-F"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197611182952119"},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.56.655.368"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6591.180"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(86)80097-1"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)91315-4"},{"key":"e_1_2_1_91_1","first-page":"450","article-title":"Liver involvement after treatment with naproxen","volume":"142","author":"Krogsgaard K.","year":"1980","unstructured":"Krogsgaard K., Harcht F., Malchow-Miller A. Liver involvement after treatment with naproxen. Ugesker Laeger 1980; 142: 450","journal-title":"Ugesker Laeger"},{"key":"e_1_2_1_92_1","first-page":"250","article-title":"Naproxen e icteria","volume":"29","author":"Lagarriga J","year":"1975","unstructured":"Lagarriga J. Naproxen e icteria. Rev. Sanid. Milit. 1975; 29: 250","journal-title":"Rev. Sanid. Milit."},{"key":"e_1_2_1_93_1","first-page":"322","article-title":"Fulminating hepatitis after treatment with naproxen and\/or disulfiram","volume":"111","author":"Bell H.","year":"1991","unstructured":"Bell H., Raknered N. Fulminating hepatitis after treatment with naproxen and\/or disulfiram. Tiddskr. Nortluegefuran 1991; 111: 322","journal-title":"Tiddskr. Nortluegefuran"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199101020-00005"},{"key":"e_1_2_1_95_1","first-page":"12","article-title":"Pharmacokinetics studies of benoxaprofen after therapeutic doses with a review of related pharmacokinetics metabolic studies","volume":"7","author":"Nash J. F.","year":"1980","unstructured":"Nash J. F., Carmichael R. H., Ridolfo A. S., Spradin C. T. Pharmacokinetics studies of benoxaprofen after therapeutic doses with a review of related pharmacokinetics metabolic studies. J. Rheumatol. (Suppl.) 1980; 7: 12","journal-title":"J. Rheumatol. (Suppl.)"},{"key":"e_1_2_1_96_1","first-page":"69","article-title":"The pharmacokinetics of benoxaprofen in elderly subjects","volume":"5","author":"Hamdy R. C.","year":"1982","unstructured":"Hamdy R. C., Murnang B., Pereran, Hlafsak R. L., Weber J. P. The pharmacokinetics of benoxaprofen in elderly subjects. Eur. J. Rheumatol. Inflamm. 1982; 5: 69","journal-title":"Eur. J. Rheumatol. Inflamm."},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6326.1372"},{"key":"e_1_2_1_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91953-5"},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6331.1783"},{"key":"e_1_2_1_100_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6331.1784"},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6331.1783-a"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.285.6334.62"},{"key":"e_1_2_1_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6329.1630-b"},{"key":"e_1_2_1_104_1","first-page":"23","article-title":"H\u00e9patite au pirprof\u00e8ne","volume":"22","author":"Fouin-Fortunet H.","year":"1986","unstructured":"Fouin-Fortunet H., Lerebours E., Bernet J., Hemet J., Colin R. H\u00e9patite au pirprof\u00e8ne. Annu. Gastroenterol. Hepatol. 1986; 22: 23","journal-title":"Annu. Gastroenterol. Hepatol."},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(85)90765-6"},{"key":"e_1_2_1_106_1","first-page":"297","article-title":"H\u00e9patites au pirprof\u00e8ne d'\u00e9volution favorable","volume":"39","author":"Castot A.","year":"1984","unstructured":"Castot A., Netter P., Arnaudo J. P., Andrieu J., Vicari F., Ponge B., Wilhelm J. M., Danan G., Trechot P., Felon J. H. H\u00e9patites au pirprof\u00e8ne d'\u00e9volution favorable. Th\u00e9rapie 1984; 39: 297","journal-title":"Th\u00e9rapie"},{"key":"e_1_2_1_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(87)80019-3"},{"key":"e_1_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1980.tb02536.x"},{"key":"e_1_2_1_109_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1979.tb01617.x"},{"key":"e_1_2_1_110_1","first-page":"865","article-title":"A double-blind comparison of aspirin and pirprofen in the treatment of rheumatoid arthritis","volume":"7","author":"Singleton C. M.","year":"1980","unstructured":"Singleton C. M., Wild J. H. A double-blind comparison of aspirin and pirprofen in the treatment of rheumatoid arthritis. J. Rheumatol. 1980; 7: 865","journal-title":"J. Rheumatol."},{"key":"e_1_2_1_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)39166-4"},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01073079"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-59-1-97"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/14.2.71"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0007-1935(17)39031-0"},{"key":"e_1_2_1_116_1","first-page":"423","article-title":"The protective effect of L-ornithine-L-aspartate on the liver in rats with drug-induced liver damage","volume":"6","author":"Zicha M","year":"1968","unstructured":"Zicha M. The protective effect of L-ornithine-L-aspartate on the liver in rats with drug-induced liver damage. Z. Gastroenterol 1968; 6: 423","journal-title":"Z. Gastroenterol"},{"key":"e_1_2_1_117_1","first-page":"263","article-title":"Untersuchungen zum Mechanismus der Enzyminduktion. XV. Induktionsmuster und submikroskopische Ver\u00e4nderungen in der Leber nach Applikation von Phenylbutazone bei unterschiedlich alten Ratten","volume":"24","author":"Klinger W.","year":"1970","unstructured":"Klinger W., Elger J., Franke H., Riencke C., Traeger A., Volkann H., Wahtenberg T., Ankerman H. Untersuchungen zum Mechanismus der Enzyminduktion. XV. Induktionsmuster und submikroskopische Ver\u00e4nderungen in der Leber nach Applikation von Phenylbutazone bei unterschiedlich alten Ratten. Acta Biol. Med. Germ. 1970; 24: 263","journal-title":"Acta Biol. Med. Germ."},{"key":"e_1_2_1_118_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198428040-00002"},{"key":"e_1_2_1_119_1","first-page":"343","article-title":"Prolonged cholestatic jaundice and leukopenia associated with piroxicam","volume":"22","author":"Hartmann H.","year":"1984","unstructured":"Hartmann H., Fischer G., Janning G. Prolonged cholestatic jaundice and leukopenia associated with piroxicam. Z. Gastroenterol. 1984; 22: 343","journal-title":"Z. Gastroenterol."},{"key":"e_1_2_1_120_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6546.540"},{"key":"e_1_2_1_121_1","first-page":"980","article-title":"Hepatitis due to non-steroidal antiinflammatory agents: a new involved molecule, piroxicam (Feldene)","volume":"12","author":"Zarski J. P.","year":"1984","unstructured":"Zarski J. P., Aubert H., Dentant L., Rachail M. Hepatitis due to non-steroidal antiinflammatory agents: a new involved molecule, piroxicam (Feldene). Gastroent\u00e9rol. Clin. Biol. 1984; 12: 980","journal-title":"Gastroent\u00e9rol. Clin. Biol."},{"key":"e_1_2_1_122_1","first-page":"468","article-title":"Fatal submassive necrosis of the liver associated with piroxicam","volume":"5","author":"Planas R.","year":"1990","unstructured":"Planas R., Leon R. D., Quer J. C., Barranco C., Bruguera M., Gassull M. A. Fatal submassive necrosis of the liver associated with piroxicam. Am. J. Gastroenterol. 1990; 5: 468","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-337"},{"key":"e_1_2_1_124_1","first-page":"898","article-title":"Piroxicam hepatotoxicity","volume":"85","author":"Caballeria E.","year":"1990","unstructured":"Caballeria E., Masso R. M., Arago I. V., Sanchis A. Piroxicam hepatotoxicity. Am. J. Gastroenterol. 1990; 85: 898","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90417-J"},{"key":"e_1_2_1_126_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.10.1436"},{"key":"e_1_2_1_127_1","first-page":"105","volume-title":"Anti-Inflammatory and Anti-Rheumatic Drugs","author":"Godfrey K. E.","year":"1985","unstructured":"Godfrey K. E., Swain M. C. Fenclofenac. Anti-Inflammatory and Anti-Rheumatic Drugs, K. D. Rainsford. CRC Press, Boca Raton, FL 1985; 105"},{"key":"e_1_2_1_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0307-742X(21)00079-5"},{"key":"e_1_2_1_129_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1981.00340030065013"},{"key":"e_1_2_1_130_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.28.040188.002055"},{"key":"e_1_2_1_131_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040486"},{"key":"e_1_2_1_132_1","first-page":"H3","article-title":"Physiopathologie des h\u00e9patopathies m\u00e9dicamenteuses","volume":"17","author":"Pessayre D","year":"1993","unstructured":"Pessayre D. Physiopathologie des h\u00e9patopathies m\u00e9dicamenteuses. Gastroent\u00e9rol. Clin. Biol. 1993; 17: H3","journal-title":"Gastroent\u00e9rol. Clin. Biol."},{"key":"e_1_2_1_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(92)90226-F"},{"key":"e_1_2_1_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(93)90285-B"},{"key":"e_1_2_1_135_1","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1993.1097"},{"key":"e_1_2_1_136_1","first-page":"189","article-title":"A major role for cytochrome P450TB (CYP2C subfamily) in the actions of non-steroidal antiinflammatory drugs","volume":"19","author":"Leemann T. D.","year":"1993","unstructured":"Leemann T. D., Transon C., Bonnabry P., Dayer P. A major role for cytochrome P450TB (CYP2C subfamily) in the actions of non-steroidal antiinflammatory drugs. Drugs Exptl. Clin. Res. 1993; 19: 189","journal-title":"Drugs Exptl. Clin. Res."},{"key":"e_1_2_1_137_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199000405-00004"},{"key":"e_1_2_1_138_1","first-page":"808","article-title":"Evidence for the role of reactive metabolites in hepatotoxicity of benoxaprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs)","volume":"3","author":"Mitchell M. C.","year":"1983","unstructured":"Mitchell M. C., Lietman P. S. Evidence for the role of reactive metabolites in hepatotoxicity of benoxaprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs). Hepatology 1983; 3: 808","journal-title":"Hepatology"},{"key":"e_1_2_1_139_1","first-page":"413","volume-title":"Handbook of Inflammation, Vol. 5, The Pharmacology of Inflammation","author":"Brune K.","year":"1985","unstructured":"Brune K., Lanz R. Pharmacokinetics of nonsteroidal anti-inflammatory drugs. Handbook of Inflammation, Vol. 5, The Pharmacology of Inflammation, I. L. Bonta, M. A. Bray, M. J. Parnham. Elsevier, Amsterdam 1985; 413"},{"key":"e_1_2_1_140_1","first-page":"13","article-title":"Towards safer nonsteroidal anti-inflammatory drugs","volume":"32","author":"Brune K.","year":"1991","unstructured":"Brune K., Beck W. S. Towards safer nonsteroidal anti-inflammatory drugs. Agents Actions 1991; 32: 13, Suppl.","journal-title":"Agents Actions"},{"key":"e_1_2_1_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(25)08633-7"},{"key":"e_1_2_1_142_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1974.tb09290.x"},{"key":"e_1_2_1_143_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498257909042327"},{"key":"e_1_2_1_144_1","first-page":"49","volume-title":"Anti-inflammatory and Anti-Rheumatic Drugs","author":"Sengupta C.","year":"1985","unstructured":"Sengupta C., Af\u00e8che P., Meyer-Brunot H. G., Rensing U. Diclofenac sodium. Anti-inflammatory and Anti-Rheumatic Drugs, K. D. Rainsford. CRC Press, Boca Raton, FL 1985; 49"},{"key":"e_1_2_1_145_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498259109039480"},{"key":"e_1_2_1_146_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150328"},{"key":"e_1_2_1_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(91)90065-T"},{"key":"e_1_2_1_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)10294-2"},{"key":"e_1_2_1_149_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.32.040192.000325"},{"key":"e_1_2_1_150_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199223040-00005"},{"key":"e_1_2_1_151_1","doi-asserted-by":"publisher","DOI":"10.3109\/03602539208996289"},{"key":"e_1_2_1_152_1","first-page":"157","article-title":"Acyl glucuronide conjugates: reactive metabolites of non-steroidal anti-inflammatory drugs","volume":"36","author":"Dickinson R. G","year":"1993","unstructured":"Dickinson R. G. Acyl glucuronide conjugates: reactive metabolites of non-steroidal anti-inflammatory drugs. Proc. West. Pharmacol. Soc. 1993; 36: 157","journal-title":"Proc. West. Pharmacol. Soc."},{"key":"e_1_2_1_153_1","doi-asserted-by":"publisher","DOI":"10.3109\/03602538409033562"},{"key":"e_1_2_1_154_1","first-page":"318","article-title":"Acylation of albumin by 1-O-acyl glucuronides","volume":"13","author":"Van Breemen R. B.","year":"1985","unstructured":"Van Breemen R. B., Fenselau C. Acylation of albumin by 1-O-acyl glucuronides. Drug Metab. Disp. 1985; 13: 318","journal-title":"Drug Metab. Disp."},{"key":"e_1_2_1_155_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199325020-00004"},{"key":"e_1_2_1_156_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02353408"},{"key":"e_1_2_1_157_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498258709044004"},{"key":"e_1_2_1_158_1","first-page":"545","article-title":"Diclofenac sodium","volume":"8","author":"Small R. E","year":"1989","unstructured":"Small R. E. Diclofenac sodium. Clin. Pharmacy. 1989; 8: 545","journal-title":"Clin. Pharmacy."},{"key":"e_1_2_1_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(93)90245-R"},{"key":"e_1_2_1_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(92)90012-8"},{"key":"e_1_2_1_161_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198308040-00003"},{"key":"e_1_2_1_162_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-5134-4_42"},{"key":"e_1_2_1_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(93)90279-C"},{"key":"e_1_2_1_164_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112392"},{"key":"e_1_2_1_165_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(25)08612-X"},{"key":"e_1_2_1_166_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498259309057022"},{"key":"e_1_2_1_167_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.9.3797"},{"key":"e_1_2_1_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(25)08441-7"},{"key":"e_1_2_1_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90233-U"},{"key":"e_1_2_1_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(25)07464-1"},{"key":"e_1_2_1_171_1","first-page":"S-214","article-title":"Carprofen acyl glucuronides: stereoselective degradation and interaction with human serum albumin","volume":"5","author":"Iwakawa S.","year":"1988","unstructured":"Iwakawa S., Spahn H., Benet L. Z., Lin E. T. Carprofen acyl glucuronides: stereoselective degradation and interaction with human serum albumin. Pharm. Res. 1988; 5: S-214, Suppl.","journal-title":"Pharm. Res."},{"key":"e_1_2_1_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(25)08822-1"},{"key":"e_1_2_1_173_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.120"},{"key":"e_1_2_1_174_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.5"},{"key":"e_1_2_1_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(93)90248-U"},{"key":"e_1_2_1_176_1","doi-asserted-by":"publisher","DOI":"10.1159\/000139112"},{"key":"e_1_2_1_177_1","first-page":"339","article-title":"Covalent binding of diflunisal and probenecid to plasma protein in humans: persistence of the adducts in the circulation","volume":"66","author":"McKinnon G. E.","year":"1989","unstructured":"McKinnon G. E., Dickinson R. G. Covalent binding of diflunisal and probenecid to plasma protein in humans: persistence of the adducts in the circulation. Res. Comm. Chem. Pathol. Pharmacol. 1989; 66: 339","journal-title":"Res. Comm. Chem. Pathol. Pharmacol."},{"key":"e_1_2_1_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(91)91259-F"},{"key":"e_1_2_1_179_1","article-title":"Studies on the reactivity of acyl glucuronides. VIII. Generation of an antiserum for the detection of diflunisal-modified proteins in diflunisal-dosed rats","author":"Williams A. M.","unstructured":"Williams A. M., Worrall S., Dejersey J., Dickinson R. G. Studies on the reactivity of acyl glucuronides. VIII. Generation of an antiserum for the detection of diflunisal-modified proteins in diflunisal-dosed rats. Biochem. Pharmacol., in press","journal-title":"Biochem. Pharmacol."},{"key":"e_1_2_1_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(93)90466-A"},{"key":"e_1_2_1_181_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1990.tb15404.x"},{"key":"e_1_2_1_182_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015985805042"},{"key":"e_1_2_1_183_1","first-page":"253","article-title":"Immunochemical detection of a major diclofenac-protein adduct in mouse liver: possible role in hepatotoxicity","volume":"12","author":"Pumford N. R.","year":"1992","unstructured":"Pumford N. R., Davila J. C., Myers T. G., Pohl L. R. Immunochemical detection of a major diclofenac-protein adduct in mouse liver: possible role in hepatotoxicity. Toxicologist 1992; 12: 253","journal-title":"Toxicologist"},{"key":"e_1_2_1_184_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx00032a002"},{"key":"e_1_2_1_185_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx00040a014"},{"key":"e_1_2_1_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-895X(25)09919-5"},{"key":"e_1_2_1_187_1","first-page":"425","article-title":"Liver, lung, and spleen as target tissues for protein adduct formation associated with metabolism of the nonsteroidal antiinflammatory drug diclofenac","volume":"14","author":"Kretz-Rommel A.","year":"1994","unstructured":"Kretz-Rommel A., Boelsterli U. A. Liver, lung, and spleen as target tissues for protein adduct formation associated with metabolism of the nonsteroidal antiinflammatory drug diclofenac. Toxicologist 1994; 14: 425","journal-title":"Toxicologist"},{"key":"e_1_2_1_188_1","first-page":"253","article-title":"Covalent binding of diclofenac to plasma membrane proteins of the bile canaliculi in the mouse","volume":"12","author":"Myers T. G.","year":"1992","unstructured":"Myers T. G., Pumford N. R., Davila J. C., Pohl L. R. Covalent binding of diclofenac to plasma membrane proteins of the bile canaliculi in the mouse. Toxicologist 1992; 12: 253","journal-title":"Toxicologist"},{"key":"e_1_2_1_189_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840090503"},{"key":"e_1_2_1_190_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-895X(25)14180-1"},{"key":"e_1_2_1_191_1","first-page":"575","volume-title":"Clinical Aspects of Immunology","author":"Coombs R. R. A.","year":"1968","unstructured":"Coombs R. R. A., Gell P. G. H. Classification of allergic reactions responsible for clinical hypersensitivity and disease. Clinical Aspects of Immunology, R. R. A. Coombs, P. G. H. Gell. F. A. Davis, New York 1968; 575"},{"key":"e_1_2_1_192_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-642-69088-4_3","volume-title":"Allergic Reactions to Drugs","author":"De Week A. L","year":"1983","unstructured":"De Week A. L. Immunopafhological mechanisms and clinical aspects of allergic reactions to drugs. Allergic Reactions to Drugs, A. L. De Week, H. Bungaard. Springer-Verlag, Berlin 1983; 75"},{"key":"e_1_2_1_193_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080302"},{"key":"e_1_2_1_194_1","first-page":"251","article-title":"Purified hepatocytes can stimulate allospecific cytoloytic T lymphocytes in a mixed lymphocyte-hepatocyte culture","volume":"19","author":"So S. K. S.","year":"1987","unstructured":"So S. K. S., Platt J. L., Ascher N. L., Simmons R. L. Purified hepatocytes can stimulate allospecific cytoloytic T lymphocytes in a mixed lymphocyte-hepatocyte culture. Transplant Proc. 1987; 19: 251","journal-title":"Transplant Proc."},{"key":"e_1_2_1_195_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198608000-00001"},{"key":"e_1_2_1_196_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90034-A"},{"key":"e_1_2_1_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90778-W"},{"key":"e_1_2_1_198_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80278-8"},{"key":"e_1_2_1_199_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120208"},{"key":"e_1_2_1_200_1","first-page":"73","volume-title":"Progress in Liver Diseases","author":"Van den Oord J.","year":"1990","unstructured":"Van den Oord J., De Vos R., Desmet V. J. HLA expression in liver disease. Progress in Liver Diseases, H. Popper, F. Schaffner. W.B. Saunders, Philadelphia 1990; Vol. 9: 73"},{"key":"e_1_2_1_201_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80121-7"},{"key":"e_1_2_1_202_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840050504"},{"key":"e_1_2_1_203_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0940-2993(11)80391-X"},{"key":"e_1_2_1_204_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90480-E"},{"key":"e_1_2_1_205_1","doi-asserted-by":"publisher","DOI":"10.1038\/369031a0"},{"key":"e_1_2_1_206_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198007103030202"},{"key":"e_1_2_1_207_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.11.1233"},{"key":"e_1_2_1_208_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220132"},{"key":"e_1_2_1_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/0887-2333(91)90087-T"},{"key":"e_1_2_1_210_1","first-page":"769","article-title":"H\u00e9patites \u00e0 la clom\u00e9tacine (Dup\u00e9ran\u00ae). Etude r\u00e9trospective de 30 cas. Un mod\u00e8le d'h\u00e9patite autoimmune m\u00e9dicamenteuse","volume":"13","author":"Pariente E. A.","year":"1989","unstructured":"Pariente E. A., Hamoud A., Goldfain D., Latrive J. P., Gislon J., Cassan P., Morin T., Staub J.-L., Ramain J.-P., Bertrand J.-L., Denis J., Lafon J., Labayle D., Druart F., Bianchi A., Kammerer J. H\u00e9patites \u00e0 la clom\u00e9tacine (Dup\u00e9ran\u00ae). Etude r\u00e9trospective de 30 cas. Un mod\u00e8le d'h\u00e9patite autoimmune m\u00e9dicamenteuse. Gastroent\u00e9rol. Clin. Biol. 1989; 13: 769","journal-title":"Gastroent\u00e9rol. Clin. Biol."},{"key":"e_1_2_1_211_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916939109035142"},{"key":"e_1_2_1_212_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01536005"},{"key":"e_1_2_1_213_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120225"},{"key":"e_1_2_1_214_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180411"},{"key":"e_1_2_1_215_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.09.040191.002425"},{"key":"e_1_2_1_216_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230213"},{"key":"e_1_2_1_217_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.11.040193.000455"},{"key":"e_1_2_1_218_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916938909014685"},{"key":"e_1_2_1_219_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498257809060392"},{"key":"e_1_2_1_220_1","doi-asserted-by":"publisher","DOI":"10.1080\/15287398509530752"},{"key":"e_1_2_1_221_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498258809041712"},{"key":"e_1_2_1_222_1","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(86)90064-8"},{"key":"e_1_2_1_223_1","doi-asserted-by":"publisher","DOI":"10.1016\/0887-2333(94)90208-9"},{"key":"e_1_2_1_224_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(92)90196-V"},{"key":"e_1_2_1_225_1","first-page":"267","article-title":"Pharmacological studies of a new antiinflammatory drug, benoxaprofen. III. Effect on the hepatic drug-metabolizing enzyme system","volume":"23","author":"Matsubara T.","year":"1982","unstructured":"Matsubara T., Touchi A., Masuda Y. Pharmacological studies of a new antiinflammatory drug, benoxaprofen. III. Effect on the hepatic drug-metabolizing enzyme system. Oyo Yakuri 1982; 23: 267","journal-title":"Oyo Yakuri"},{"key":"e_1_2_1_226_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-6618(09)80055-8"},{"key":"e_1_2_1_227_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(82)90210-6"},{"key":"e_1_2_1_228_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(89)90237-2"},{"key":"e_1_2_1_229_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(93)90315-N"},{"key":"e_1_2_1_230_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(86)90443-0"},{"key":"e_1_2_1_231_1","first-page":"59","article-title":"Interactions of anti-inflammatory 2-arylpropionates (profens) with the metabolism of fatty acids:in vitro studies","volume":"16","author":"Mayer J. M.","year":"1994","unstructured":"Mayer J. M., Roy-de-Vos M., Audergon C., Testa B., Etter J. C. Interactions of anti-inflammatory 2-arylpropionates (profens) with the metabolism of fatty acids:in vitro studies. Int. J. Tiss. Reac. 1994; 16: 59","journal-title":"Int. J. Tiss. Reac."},{"key":"e_1_2_1_232_1","volume-title":"Handbook of Experimental Pharmacology. Pharmacokinetics and Drug Metabolism","author":"Mayer J.","year":"1994","unstructured":"Mayer J., Testa B. Stereoselectivity in metabolic reactions of toxication and detoxication. Handbook of Experimental Pharmacology. Pharmacokinetics and Drug Metabolism, L. P. Ballant, P. G. Welling. Springer, Stuttgart 1994, in press"},{"key":"e_1_2_1_233_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(83)90107-7"},{"key":"e_1_2_1_234_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)22933-0"},{"key":"e_1_2_1_235_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498257909038733"},{"key":"e_1_2_1_236_1","first-page":"411","volume-title":"Modulation of Liver Cell Expression","author":"Trudell J. R.","year":"1987","unstructured":"Trudell J. R., Gut J., Costa A. K. Leukotrienes in hepatocyte injury. Modulation of Liver Cell Expression, W. Reutter, P. C. Heinrich, H. Popper, D. Keppler, I. M. Arias, L. Landmann. MTP Press, Lancaster 1987; 411"},{"key":"e_1_2_1_237_1","first-page":"423","volume-title":"Modulation of Liver Cell Expression","author":"Hagmann W.","year":"1987","unstructured":"Hagmann W., Kirn A., Keppler D. Role of leukotrienes in acute inflammatory liver disease. Modulation of Liver Cell Expression, W. Reutter, P. C. Heinrich, H. Popper, D. Keppler, I. M. Arias, L. Landmann. MTP Press, Lancaster 1987; 423"},{"key":"e_1_2_1_238_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.154.3.311"},{"key":"e_1_2_1_239_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03794.x"},{"key":"e_1_2_1_240_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00542448"},{"key":"e_1_2_1_241_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02899413"},{"key":"e_1_2_1_242_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.149.2.706"},{"key":"e_1_2_1_243_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1992.tb17456.x"},{"key":"e_1_2_1_244_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-895X(25)12947-7"},{"key":"e_1_2_1_245_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00057a013"},{"key":"e_1_2_1_246_1","first-page":"2","article-title":"Pharmacologic studies with a new class of nonsteroidal anti-inflammatory agents \u2014 the oxicams \u2014 with special reference to piroxicam (Feldene\u00ae)","volume":"72","author":"Wiseman E. H","year":"1982","unstructured":"Wiseman E. H. Pharmacologic studies with a new class of nonsteroidal anti-inflammatory agents \u2014 the oxicams \u2014 with special reference to piroxicam (Feldene\u00ae). Am. J. Med. 1982; 72: 2","journal-title":"Am. J. Med."}],"container-title":["Critical Reviews in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10408449509089888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:03:05Z","timestamp":1770886985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10408449509089888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":245,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["10.3109\/10408449509089888"],"URL":"https:\/\/doi.org\/10.3109\/10408449509089888","relation":{},"ISSN":["1040-8444","1547-6898"],"issn-type":[{"value":"1040-8444","type":"print"},{"value":"1547-6898","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}